FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114510400> ?p ?o ?g. }

• W2114510400 endingPage "F782" @default.
• W2114510400 startingPage "F777" @default.
• W2114510400 abstract "Peritoneal dialysis (PD) is a life-sustaining therapy for end-stage renal disease (ESRD), used by 10-15% of the dialysis population worldwide. Peritoneal fibrosis (PF) is a known complication of long-term PD and frequently follows episodes of peritonitis, rendering the peritoneal membrane inadequate for dialysis. Transforming growth factor (TGF)-β is an inducer of fibrosis in several tissues and organs, and its overexpression has been correlated with PF. Animal models of peritonitis have shown an increase in expression of TGF-β in the peritoneal tissue. Decorin, a proteoglycan and component of the extracellular matrix, inactivates TGF-β, consequently reducing fibrosis in many tissues. Recently, gold nanoparticles (GNP) have been used for drug delivery in a variety of settings. In the present study, we tested the possibility that GNP-delivered decorin gene therapy ameliorates zymosan-mediated PF. We created a PF model using zymosan-induced peritonitis. Rats were treated with no decorin, GNP-decorin, or adeno-associated virus-decorin (AAV-decorin) and compared with controls. Tissue samples were then stained for Masson's trichrome, enface silver, and hematoxylin and eosin, and immunohistochemistry was carried out with antibodies to TGF-β1, α-smooth muscle actin (α-SMA), and VEGF. Animals which were treated with GNP-decorin and AAV-decorin gene therapy had significant reductions in PF compared with untreated animals. Compared with untreated animals, the treated animals had better preserved peritoneal mesothelial cell size, a significant decrease in peritoneal thickness, and decreased α-SMA. Quantitative PCR measurements showed a significant decrease in the peritoneal tissue levels of α-SMA, TGF-β, and VEGF in treated vs. untreated animals. This study shows that both GNP-delivered and AAV-mediated decorin gene therapies significantly decrease PF in vivo in a rodent model. This approach has important clinical translational potential in providing a therapeutic strategy to prevent PF in PD patients." @default.
• W2114510400 created "2016-06-24" @default.
• W2114510400 creator A5012849717 @default.
• W2114510400 creator A5019935802 @default.
• W2114510400 creator A5023700408 @default.
• W2114510400 creator A5045952992 @default.
• W2114510400 creator A5058413340 @default.
• W2114510400 creator A5083245037 @default.
• W2114510400 date "2014-10-01" @default.
• W2114510400 modified "2023-09-26" @default.
• W2114510400 title "Nanotechnology and adeno-associated virus-based decorin gene therapy ameliorates peritoneal fibrosis" @default.
• W2114510400 cites W1536476892 @default.
• W2114510400 cites W1760215417 @default.
• W2114510400 cites W1971424145 @default.
• W2114510400 cites W1976363248 @default.
• W2114510400 cites W1980534733 @default.
• W2114510400 cites W1980836692 @default.
• W2114510400 cites W1985400766 @default.
• W2114510400 cites W1986362585 @default.
• W2114510400 cites W1991084867 @default.
• W2114510400 cites W1991634879 @default.
• W2114510400 cites W1994025696 @default.
• W2114510400 cites W1996139192 @default.
• W2114510400 cites W1996501936 @default.
• W2114510400 cites W1996764985 @default.
• W2114510400 cites W2005922664 @default.
• W2114510400 cites W2021354068 @default.
• W2114510400 cites W2037473257 @default.
• W2114510400 cites W2044614528 @default.
• W2114510400 cites W2045133262 @default.
• W2114510400 cites W2053352199 @default.
• W2114510400 cites W2071046812 @default.
• W2114510400 cites W2089237847 @default.
• W2114510400 cites W2101417810 @default.
• W2114510400 cites W2110346484 @default.
• W2114510400 cites W2122106424 @default.
• W2114510400 cites W2127266890 @default.
• W2114510400 cites W2130030207 @default.
• W2114510400 cites W2130322678 @default.
• W2114510400 cites W2131456519 @default.
• W2114510400 cites W2135559148 @default.
• W2114510400 cites W2137109959 @default.
• W2114510400 cites W2148184356 @default.
• W2114510400 cites W2151169472 @default.
• W2114510400 cites W2154568166 @default.
• W2114510400 cites W2158547458 @default.
• W2114510400 cites W2166678051 @default.
• W2114510400 cites W2170331002 @default.
• W2114510400 cites W2172052404 @default.
• W2114510400 cites W305089212 @default.
• W2114510400 doi "https://doi.org/10.1152/ajprenal.00653.2013" @default.
• W2114510400 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4187047" @default.
• W2114510400 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25056353" @default.
• W2114510400 hasPublicationYear "2014" @default.
• W2114510400 type Work @default.
• W2114510400 sameAs 2114510400 @default.
• W2114510400 citedByCount "24" @default.
• W2114510400 countsByYear W21145104002015 @default.
• W2114510400 countsByYear W21145104002016 @default.
• W2114510400 countsByYear W21145104002017 @default.
• W2114510400 countsByYear W21145104002018 @default.
• W2114510400 countsByYear W21145104002019 @default.
• W2114510400 countsByYear W21145104002020 @default.
• W2114510400 countsByYear W21145104002021 @default.
• W2114510400 countsByYear W21145104002022 @default.
• W2114510400 countsByYear W21145104002023 @default.
• W2114510400 crossrefType "journal-article" @default.
• W2114510400 hasAuthorship W2114510400A5012849717 @default.
• W2114510400 hasAuthorship W2114510400A5019935802 @default.
• W2114510400 hasAuthorship W2114510400A5023700408 @default.
• W2114510400 hasAuthorship W2114510400A5045952992 @default.
• W2114510400 hasAuthorship W2114510400A5058413340 @default.
• W2114510400 hasAuthorship W2114510400A5083245037 @default.
• W2114510400 hasBestOaLocation W21145104002 @default.
• W2114510400 hasConcept C126322002 @default.
• W2114510400 hasConcept C142724271 @default.
• W2114510400 hasConcept C189165786 @default.
• W2114510400 hasConcept C203014093 @default.
• W2114510400 hasConcept C2779056158 @default.
• W2114510400 hasConcept C2779335624 @default.
• W2114510400 hasConcept C2779457992 @default.
• W2114510400 hasConcept C2779794767 @default.
• W2114510400 hasConcept C2780559512 @default.
• W2114510400 hasConcept C2908647359 @default.
• W2114510400 hasConcept C71924100 @default.
• W2114510400 hasConcept C86803240 @default.
• W2114510400 hasConcept C95444343 @default.
• W2114510400 hasConcept C99454951 @default.
• W2114510400 hasConceptScore W2114510400C126322002 @default.
• W2114510400 hasConceptScore W2114510400C142724271 @default.
• W2114510400 hasConceptScore W2114510400C189165786 @default.
• W2114510400 hasConceptScore W2114510400C203014093 @default.
• W2114510400 hasConceptScore W2114510400C2779056158 @default.
• W2114510400 hasConceptScore W2114510400C2779335624 @default.
• W2114510400 hasConceptScore W2114510400C2779457992 @default.
• W2114510400 hasConceptScore W2114510400C2779794767 @default.
• W2114510400 hasConceptScore W2114510400C2780559512 @default.
• W2114510400 hasConceptScore W2114510400C2908647359 @default.

• next